As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >


Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >


Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
November 22, 2022 – 4:00 pm (CET)

Genopole boosts the growth of innovative entrepreneurs

Do you want to develop your company or set up a Subsidiary Office in France at Genopole ?

The aim of this webinar is to give you a better understanding of Genopole’s assets, as well as the support offered to help you set up your business.
Numerous testimonials will illustrate, through concrete cases, the possibilities offered by an exceptional location.
Registration >

Following the success of the first webinar organised in collaboration with the Geolink Expansion and Invest-HUB teams, Genopole is doing it again. Scheduled for Tuesday 22 November at 4pm, this new meeting will be an opportunity for entrepreneurs and innovative project leaders in the biotech sector to discover a unique ecosystem in Europe’s most attractive country. It will also be an opportunity to find out more about an ambitious biocluster that has embarked on a vast development programme to promote the growth of companies in the sector, whatever their degree of maturity. 

France has never been so attractive to international investors. Last year, more than 1,600 investment projects chose France to develop, including 247 from the United States. The Brexit, France’s central position within the European market, the quality of its infrastructure, the favourable tax system for R&D and the ambitious recovery plan put in place by the public authorities all contribute significantly to this attraction for France.

As France’s leading biocluster and incubator for biotechnological innovations, Genopole® has embarked on an ambitious real estate programme to meet the numerous demands for office and laboratory space. This is a godsend for young project leaders and more mature biotech companies looking for the ideal setting to accelerate their development in a unique living environment, only a few kilometres from Paris.

The aim of this webinar is to tell you more about the advantages of a unique site that is completing its transformation to offer unique development conditions for professionals in the biotech sector.


Introduction  – Presentation of Genopole

Laurent Pépin, Director of Business Development and Partnerships – Genopole

Introduction – Destination France / Aid form the region Ile-de-France

Yann Masson, Life Sciences & Sport expert Choose Paris Region

A real estate structure dedicated to setting up companies in Genopole

Laurent Pépin, Director of Business Development and Partnerships – Genopole

Genopole changes dimension !

Steven Marcus, Real Estate Development at Patriarche


– Abolis – Valérie Brunel, director general
– Endogen Bio
– Yposkesi
With the support from
Région île de France